Ozempic reduces risk of serious illness and death in people with diabetes and kidney disease, study finds
By Deidre McPhillips, CNN (CNN) — Weekly injections of semaglutide medications like Ozempic significantly reduce the risk of serious kidney outcomes, major cardiovascular events and death among people who have type 2 diabetes and chronic kidney disease, according to a new study. Diabetes is a key risk factor for kidney disease, which is one of
Continue Reading